AstraZeneca : AZN

All AstraZeneca Articles

218 Articles

Jon C. Ogg | Jun 30, 2010 at 8:01 AM EDT

Top Analyst Upgrades and Downgrades (AZN, EXFO, FTE, HCBK, LPX, PT, SNN, USB, VOD)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research early this Wednesday. Some…

Jon C. Ogg | May 29, 2010 at 10:34 AM EDT

The Unusual Suspects (AIG, AZN, BRK-A, BRK-B, MCO, C, GNMK, IEP, LGF, SI, STP, PHYS, SNF, EWP, TEF)

We have an unusual cast of characters in this week’s version of THE UNUSUAL SUSPECTS for the week ahead, with…

Douglas A. McIntyre | May 19, 2010 at 8:10 PM EDT

Big Pharma Makes More Money On Kids, Use Of Medications Among The Young Rises

The pharmaceutical industry has found a growing source of sales–the prescription of medicines, primarily used by adults in the past,…

Douglas A. McIntyre | Nov 17, 2009 at 11:37 AM EST

FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)

The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved once…

Douglas A. McIntyre | Aug 20, 2009 at 7:48 AM EDT

Top 10 Analyst Upgrades & Downgrades (AZN, BDN, CHA, HURN, PRU, PETM, RF, SOL, RDS-B, TWB, UA)

These are Thursday’s top ten analyst research summary upgrades, downgrades, and initiations from Wall Street brokerage firms: AstraZeneca (AZN) Cut…

Douglas A. McIntyre | Aug 10, 2009 at 10:56 AM EDT

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so…

Douglas A. McIntyre | Jul 30, 2009 at 3:28 PM EDT

Fighting Swine Flu The Wal-Mart Way (WMT, AZN, GSK, NOVN, SNY)

You can just see the TV advertisements now… Wal-Mart and Uncle Sam are “rolling back” swine flu. The retailer is…

Douglas A. McIntyre | Jul 22, 2009 at 4:01 AM EDT

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…

Douglas A. McIntyre | Jun 25, 2009 at 11:31 AM EDT

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early…

Douglas A. McIntyre | May 14, 2009 at 6:24 AM EDT

Top 10 Analyst Upgrades & Downgrades (AZN, BAS, BRNC, BCS, DB, PCS, MYL, PTEN, PDC, WSH)

These are the top 10 early bird analyst upgrades and downgrades we have seen in Wall Street research calls early…

Douglas A. McIntyre | Apr 27, 2009 at 6:54 AM EDT

Top Analyst Upgrades (AZN, BMR, ETR, MMM, NFLX, NVO, SWK)

These are some of the top pre-market analyst upgrades we have seen from Wall Street early this Monday morning: AstraZeneca…

Douglas A. McIntyre | Apr 17, 2009 at 2:05 PM EDT

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association…

Douglas A. McIntyre | Jan 30, 2009 at 8:01 AM EST

Top Pre-Market Analyst Downgrades (ALL, AZN, ETFC, FITB, JNPR, QCOM, RF, RYAAY, SEPR, HOT, TKR, TWC, TROW, UA, VE, ZNT)

These are some of the many pre-market downgrades and negative calls we have seen from Wall Street analysts this Friday…

Douglas A. McIntyre | Jan 30, 2009 at 7:55 AM EST

Top Pre-Market Analyst Upgrades (ARAY, AZN, SAM, BSX, CNX, MLM, TER, TWX)

These are some of the top pre-market analyst upgrades and positive calls we have seen on Wall Street this Friday…

Douglas A. McIntyre | Jul 8, 2008 at 1:38 PM EDT

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic…

1 … 12 13 14 15

AstraZeneca : AZN

All AstraZeneca Articles

Top Analyst Upgrades and Downgrades (AZN, EXFO, FTE, HCBK, LPX, PT, SNN, USB, VOD)

The Unusual Suspects (AIG, AZN, BRK-A, BRK-B, MCO, C, GNMK, IEP, LGF, SI, STP, PHYS, SNF, EWP, TEF)

Big Pharma Makes More Money On Kids, Use Of Medications Among The Young Rises

FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)

Top 10 Analyst Upgrades & Downgrades (AZN, BDN, CHA, HURN, PRU, PETM, RF, SOL, RDS-B, TWB, UA)

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Fighting Swine Flu The Wal-Mart Way (WMT, AZN, GSK, NOVN, SNY)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Top 10 Analyst Upgrades & Downgrades (AZN, BAS, BRNC, BCS, DB, PCS, MYL, PTEN, PDC, WSH)

Top Analyst Upgrades (AZN, BMR, ETR, MMM, NFLX, NVO, SWK)

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

Top Pre-Market Analyst Downgrades (ALL, AZN, ETFC, FITB, JNPR, QCOM, RF, RYAAY, SEPR, HOT, TKR, TWC, TROW, UA, VE, ZNT)

Top Pre-Market Analyst Upgrades (ARAY, AZN, SAM, BSX, CNX, MLM, TER, TWX)

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

AstraZeneca : AZN

All AstraZeneca Articles

Top Analyst Upgrades and Downgrades (AZN, EXFO, FTE, HCBK, LPX, PT, SNN, USB, VOD)

The Unusual Suspects (AIG, AZN, BRK-A, BRK-B, MCO, C, GNMK, IEP, LGF, SI, STP, PHYS, SNF, EWP, TEF)

Big Pharma Makes More Money On Kids, Use Of Medications Among The Young Rises

FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)

Top 10 Analyst Upgrades & Downgrades (AZN, BDN, CHA, HURN, PRU, PETM, RF, SOL, RDS-B, TWB, UA)

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Fighting Swine Flu The Wal-Mart Way (WMT, AZN, GSK, NOVN, SNY)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Top 10 Analyst Upgrades & Downgrades (AZN, BAS, BRNC, BCS, DB, PCS, MYL, PTEN, PDC, WSH)

Top Analyst Upgrades (AZN, BMR, ETR, MMM, NFLX, NVO, SWK)

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

Top Pre-Market Analyst Downgrades (ALL, AZN, ETFC, FITB, JNPR, QCOM, RF, RYAAY, SEPR, HOT, TKR, TWC, TROW, UA, VE, ZNT)

Top Pre-Market Analyst Upgrades (ARAY, AZN, SAM, BSX, CNX, MLM, TER, TWX)

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026